IYF hits a 52-week high as rate cut hopes and regulatory rollbacks lift the outlook for U.S. financial stocks.
Vous n'êtes pas connecté
This high-yield ETF hits a new 52-week high. Are more gains in store for this ETF?
IYF hits a 52-week high as rate cut hopes and regulatory rollbacks lift the outlook for U.S. financial stocks.
New Gold (NGD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
XLG surges to a new 52-week high, gaining more than 31% from its low as tech and AI-driven market momentum lifts large caps.
XLG surges to a new 52-week high, gaining more than 31% from its low as tech and AI-driven market momentum lifts large caps.
UGI (UGI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UGI (UGI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amphenol (APH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amphenol (APH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Crown (CCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.